Leukocare
PrivateLast Round
VC Round
Jun 23, 2021
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Leukocare operates in Healthcare & Life Sciences and is based in Germany. Its latest recorded funding round was a VC Round in June 2021.
Leukocare is a biotechnology company that provides a technology platform for biopharmaceutical formulation development to improve the stability and quality of biologics like vaccines, antibodies, and viral vectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leukocare Comparables
Compare Leukocare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProJect Pharmaceutics GmbH | 87% | |
| Coriolis Pharma | 87% | |
| Pensatech Pharma GmbH | 74% |
For institutional investors. Book with your work email.
Leukocare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 23, 2021 | ||||
| VC Round | Jul 22, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Leukocare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeCare Partners | VC Round |
| Petrichor Healthcare Capital Management | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 59% MoM.
- Aug 1, 2026
Open roles increased to 46, 82% of headcount.
For institutional investors. Book with your work email.
Leukocare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Leukocare's valuation, stock price, and market status.
Is Leukocare a public or private company?
Leukocare is a private company.
What is the current stock price of Leukocare?
Leukocare is a private company, so its shares have no public market price. Caplight tracks Leukocare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leukocare worth (valuation)?
Valuation information for Leukocare is not publicly available.
Can I buy Leukocare stock?
Leukocare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leukocare's last funding round?
Leukocare's most recent funding round was VC Round on June 23, 2021.
Who are the main investors in Leukocare?
Key investors in Leukocare include LifeCare Partners, Petrichor Healthcare Capital Management.
Will Leukocare IPO soon?
No public IPO plans have been announced for Leukocare.
How can I track Leukocare secondary market activity?
Caplight tracks bids, offers, and trades in Leukocare's shares on secondary markets.